PharmTech News

Articles

Novo Nordisk’s 3.3 billion acquisition of Dicerna gives them access to their RNAi technology.

Novo Nordisk Acquires Dicerna for $3.3 Billion

Secarna Pharmaceuticals and Achilles Therapeutics have entered into an agreement to optimize the development of T cell therapies in Achilles’ pipeline.

Secarna Pharmaceuticals and Achilles Therapeutics Partner on T Cell Therapy Development

CGT Catapult and Deep Science Ventures have partnered to encourage innovative approaches to overcoming barriers in delivering advance therapies to patients.

CGT Catapult and Deep Science Ventures Team Up to Boost Innovation in Advanced Therapies

GSK has been granted approval by the EC for its monoclonal antibody therapy, Nucala (mepolizumab), as a treatment for three additional eosinophil-driven diseases.

GSK Receives European Approval for Three Additional Indications of Nucala

Novavax has announced that EMA has started its review of a conditional marketing authorization application for its COVID-19 vaccine, NVX-CoV2373.

EMA Begins Evaluation of Novavax COVID-19 Vaccine Marketing Authorization Application

Pfizer’s PAXLOVID oral solid-dosage treatment is designed to combat SARS-CoV-2 in high-risk patients at the first sign of infection.


Pfizer Submits COVID-19 Oral Antiviral Candidate to FDA for Emergency Use Authorization 

Kala’s acquisition of Combangio expands its clinical-stage biologic pipeline.

Kala Pharmaceuticals Acquires Combangio

Under the expanded agreement with Agios, Centogene will provide global clinical trial support for thalassemia and sickle cell diseases.

Centogene Expands Rare Blood Disease Partnership with Agios

AbbVie will pay REGENXBIO up to $1.75 billion for the rights to develop and commercialize its treatment of various eye conditions.

REGENXBIO and AbbVie Officially Ink Eye Care Collaboration Deal Worth Up to $1.75 Billion

European Medicines Agency (EMA) granted Rafael’s CPI-613 (devismat) an orphan drug designation for the treatment of refractory or relapsed Burkin’s lymphoma.

Bio/Pharma News